3,813 companies
10,018 AI summaries
7,618 risk analyses
3,719 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on OncoTherapy Science, Inc. (4564)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4564 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4564 Out of Scope
OncoTherapy Science, Inc.
Change Report ／ 2026-09-11 15:32
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Policy holding
Holder: Nakamura Yusuke
Stake: 6.05%
Change: -0.44pp decrease
Purpose:
As a founding shareholder of the issuer, held to strengthen ties with the issuer and accelerate research and development further as a stable shareholder.
🧩 5% holders of this company (2 holders · 10.68%)
| Holder | Stake | Change | |
|---|---|---|---|
| Nakamura Yusuke Policy | 6.05% | -0.44pp | view |
| Long Corridor Asset Management Limited Pure | 4.63% | -1.18pp | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login